Abstract
Nonalcoholic fatty liver disease (NAFLD) is a complex disease. The considerable variability in the natural history of the disease suggests an important role for genetic variants in the disease development and progression. There is evidence based on genome-wide association studies and/or candidate gene studies that genetic polymorphisms underlying insulin signaling, lipid metabolism, oxidative stress, fibrogenesis, and inflammation can predispose individuals to NAFLD. This review highlights some of the genetic variants in NAFLD.
Keywords:
GWAS; Polymorphism; SNP; Steatosis.
Copyright © 2014 Elsevier Inc. All rights reserved.
MeSH terms
-
Adipogenesis / genetics
-
Apolipoprotein C-III / genetics
-
Carrier Proteins / genetics
-
Fatty Liver / etiology*
-
Fatty Liver / genetics*
-
Fatty Liver / metabolism
-
Genetic Association Studies
-
Hemochromatosis Protein
-
Histocompatibility Antigens Class I / genetics
-
Humans
-
Lipase / genetics
-
Lipid Metabolism / genetics
-
Liver / metabolism
-
Membrane Proteins / genetics
-
Non-alcoholic Fatty Liver Disease
-
Obesity / complications*
-
Obesity / genetics*
-
Obesity / metabolism
-
Peroxisome Proliferator-Activated Receptors / genetics
-
Phosphatidate Phosphatase / genetics
-
Phosphatidylethanolamine N-Methyltransferase / genetics
-
Polymorphism, Single Nucleotide
-
Receptors, Adrenergic, beta / genetics
-
Triglycerides / metabolism
Substances
-
Apolipoprotein C-III
-
Carrier Proteins
-
HFE protein, human
-
Hemochromatosis Protein
-
Histocompatibility Antigens Class I
-
Membrane Proteins
-
Peroxisome Proliferator-Activated Receptors
-
Receptors, Adrenergic, beta
-
Triglycerides
-
microsomal triglyceride transfer protein
-
PEMT protein, human
-
Phosphatidylethanolamine N-Methyltransferase
-
Lipase
-
adiponutrin, human
-
LPIN1 protein, human
-
Phosphatidate Phosphatase